Posts Tagged ‘digital medicine’
Pending FDA review and approval, research findings pave way for Akili’s EVO to become first brain training platform prescribed for ADHD
Akili Achieves Primary Efficacy Endpoint in ADHD Trial (MD magazine): “Boston-based Akili Interactive has announced top-line results from the STARS-ADHD pivotal study of its investigational digital therapeutic medicine AKL-T01, in treatment of pediatric attention-deficit/hyperactivity disorder (ADHD)…The digital medicine, AKL-T01, is a video game for patients to play on tablet devices. It uses the same storytelling…
Read MoreThe FDA clears two computerized cognitive tests to assist in medical evaluations following brain injury or concussion
FDA allows marketing of first-of-kind computerized cognitive tests to help assess cognitive skills after a head injury (FDA news release): “The U.S. Food and Drug Administration today permitted marketing of two new devices to assess a patient’s cognitive function immediately after a suspected brain injury or concussion. The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT)…
Read MoreUpdate: Well-targeted brain training might significantly reduce dementia risk
Time for a new edition of SharpBrains’ e‑newsletter. Happy reading! New brain research ACTIVE study: Well-targeted brain training might significantly reduce dementia risk To improve brain health you need BOTH aerobic and cognitive exercise A new era of brain cartography, powered by neuroimaging and machine learning New tools for brain health and performance Akili raises an…
Read MoreAkili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table
—– Akili Adds Amgen Ventures and M Ventures* to Series B Financing, Increasing Round to $42.4 Million (press release): “Akili Interactive Labs, Inc. (“Akili”), a digital medicine company developing novel, non-pharmacological therapeutics and diagnostics for cognitive disorders, today announced an $11.9 million expansion of its recent Series B financing.
Read MoreLarge multi-center study to test videogame-like digital therapy as (potentially) FDA-cleared ADHD treatment
Akili Labs recruits for ADHD trial with ambitions of FDA clearance for digital medicine (MedCity News) “Akili Labs has kicked off open enrollment for a clinical trial of its Project EVO video game platform in a quest to secure for 510(k) clearance from the U.S. Food and Drug Administration for its lead indication
Read More